InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Regeneron Pharmaceuticals

REGN Clue Score51
United States Fiscal year ends December CIK 0000872589 Results filed 30 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Jason Pitofsky
7 Nov 2025
VP Controller
Sell
431
$651.43
$280.77K
Christopher R. Fenimore
28 Aug 2024
SVP Finance & CFO
Sell indirect
200
$1,206.67
$241.33K
Christopher R. Fenimore
28 Aug 2024
SVP Finance & CFO
Sell indirect
235
$1,205.67
$283.33K
Christopher R. Fenimore
28 Aug 2024
SVP Finance & CFO
Sell indirect
200
$1,206.70
$241.34K
Christopher R. Fenimore
28 Aug 2024
SVP Finance & CFO
Sell indirect
236
$1,205.67
$284.54K
Christopher R. Fenimore
28 Aug 2024
SVP Finance & CFO
Sell indirect
450
$1,206.15
$542.77K
Christopher R. Fenimore
28 Aug 2024
SVP Finance & CFO
Sell indirect
928
$1,205.49
$1.12M
Christopher R. Fenimore
28 Aug 2024
SVP Finance & CFO
Sell indirect
2,237
$1,204.71
$2.69M
Christopher R. Fenimore
28 Aug 2024
SVP Finance & CFO
Sell indirect
200
$1,206.30
$241.26K
Christopher R. Fenimore
28 Aug 2024
SVP Finance & CFO
Sell indirect
766
$1,205.44
$923.37K
Christopher R. Fenimore
28 Aug 2024
SVP Finance & CFO
Sell indirect
228
$1,204.79
$274.69K
Showing 250 of 2,711 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 681
Amendments (4/A) skipped 1
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 490
Sales straight out of an exercise 615
Sales at will 1,347
Transactions with no price 0
Shares from compensation/vesting 22,169,618
Sales filed before the plan box existed 1,292
History held since 3 Oct 2006